Acasti Pharma Inc
XTSX:ACST
Acasti Pharma Inc
Goodwill
Acasti Pharma Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Acasti Pharma Inc
XTSX:ACST
|
Goodwill
$8.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Goodwill
$11.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Goodwill
CA$47.5m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Goodwill
$65.4m
|
CAGR 3-Years
301%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Goodwill
$19.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Goodwill
CA$92.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Acasti Pharma Inc
Glance View
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. The firm is targeting three underserved orphan diseases: Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN). The firm's lead product candidate includes GTX-104, which is a clinical-stage nanoparticle formulation of nimodipine being developed for IV infusion in SAH patients. The firm's other pipeline products include GTX-102, an oral mucosal spray formulation of betamethasone intended to develop neurological symptoms of A-T, including developing clinical assessments of posture and gait disturbance, and kinetic speech and oculomotor functions. GTX-101 is a topical bio-adhesive film-forming spray of bupivacaine for the treatment of PHN.
See Also
What is Acasti Pharma Inc's Goodwill?
Goodwill
8.1m
USD
Based on the financial report for Mar 31, 2023, Acasti Pharma Inc's Goodwill amounts to 8.1m USD.
What is Acasti Pharma Inc's Goodwill growth rate?
Goodwill CAGR 1Y
-37%
Over the last year, the Goodwill growth was -37%.
